Medical End Period Cash Flow from 2010 to 2024
| MVP Stock | 0.42 0.01 2.33% |
End Period Cash Flow | First Reported 2003-12-31 | Previous Quarter 15.7 M | Current Value 9.7 M | Quarterly Volatility 10.8 M |
Check Medical Developments financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medical Developments' main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.6 M, Interest Expense of 78.2 K or Total Revenue of 34.8 M, as well as many indicators such as . Medical financial statements analysis is a perfect complement when working with Medical Developments Valuation or Volatility modules.
Medical | End Period Cash Flow |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Medical Stock Analysis
When running Medical Developments' price analysis, check to measure Medical Developments' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medical Developments is operating at the current time. Most of Medical Developments' value examination focuses on studying past and present price action to predict the probability of Medical Developments' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medical Developments' price. Additionally, you may evaluate how the addition of Medical Developments to your portfolios can decrease your overall portfolio volatility.